Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Galectin Therapeutics Inc., 3 years.
Galectin Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | Galectin Therapeutics Inc. | Option exercise | +31,825,235 | $3.00 | $95,475,705 |
| Jul 31, 2026 | Galectin Therapeutics Inc. | Option exercise | +2,550,932 | $4.05 | $10,331,275 |
| Jan 16, 2026 | Galectin Therapeutics Inc. | Grant or award | +13,158 | $3.04 | $40,000 |
| Jan 23, 2025 | Galectin Therapeutics Inc. | Grant or award | +32,520 | $1.23 | $40,000 |
| Jan 24, 2024 | Galectin Therapeutics Inc. | Grant or award | +23,256 | $1.72 | $40,000 |
| Sep 26, 2023 | Galectin Therapeutics Inc. | Option exercise | +1,466,204 | $5.00 | $7,331,020 |
| Sep 26, 2023 | Galectin Therapeutics Inc. | Option exercise | +170,000 | $5.00 | $850,000 |
| Sep 26, 2023 | Galectin Therapeutics Inc. | Option exercise | +200,000 | $3.00 | $600,000 |
| Sep 26, 2023 | Galectin Therapeutics Inc. | Option exercise | +200,000 | $3.26 | $652,000 |
| Sep 26, 2023 | Galectin Therapeutics Inc. | Option exercise | +200,000 | $3.00 | $600,000 |
| Jan 26, 2023 | Galectin Therapeutics Inc. | Grant or award | +36,036 | $1.11 | $40,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.